The use of direct factor Xa inhibitors (B01AF), which is a group of antithrombotic agents associated with a lower risk of subsequent redemption of other anti-dementia drugs (N06DX) (RR = 0.41, 95% CI: 0.37–0.46, P = 1.38 × 10−62) (Fig. 2b). This evidence concerns the gene F10 and dementia.